The certification enables the company's lab in Grenoble to receive patient specimens from the US for testing with its ImmuneTracker Dx cancer immunotherapy assay.
Through the acquisition, Miroculus will be able to automate and simplify the detection of miRNAs from blood using Kapplex's digital microfluidic technology.
The test, called CloNeT, is based on a novel barcoding technology that links infecting bacteria to a database of antibiotic resistance profiles.
Partnering with Biodist Group, the South Korean molecular diagnostics firm is looking to move into non-human applications such as food safety testing.
The firm postponed the launch to enhance Omni's capabilities, in the meantime focusing on opportunities in near-patient testing for its GeneXpert system.
In PLOS this week: founder mutation linked to some leukoencephalopathy cases, transcript and protein profiles of the kissing bug, and more.
BGI CEO Ye Yin says that mapping variation within the human genome will bring a "big data revolution" to healthcare, Wired UK writes.
All the images that investigators produce through their research present a challenge to share, Nature News reports.
The House of Representatives science committee has approved a measure that includes new rules for large National Science Foundation projects, ScienceInsider reports.